Neuroprotective effects of Si-based hydrogen-producing agent on 6-hydroxydopamine-induced neurotoxicity in juvenile mouse model
- PMID: 38723675
- DOI: 10.1016/j.bbr.2024.115040
Neuroprotective effects of Si-based hydrogen-producing agent on 6-hydroxydopamine-induced neurotoxicity in juvenile mouse model
Abstract
Neurotoxins have been extensively investigated, particularly in the field of neuroscience. They induce toxic damage, oxidative stress, and inflammation on neurons, triggering neuronal dysfunction and neurodegenerative diseases. Here we demonstrate the neuroprotective effect of a silicon (Si)-based hydrogen-producing agent (Si-based agent) in a juvenile neurotoxic mouse model induced by 6-hydroxydopamine (6-OHDA). The Si-based agent produces hydrogen in bowels and functions as an antioxidant and anti-inflammatory agent. However, the effects of the Si-based agent on neural degeneration in areas other than the lesion and behavioral alterations caused by it are largely unknown. Moreover, the neuroprotective effects of Si-based agent in the context of lactation and use during infancy have not been explored in prior studies. In this study, we show the neuroprotective effect of the Si-based agent on 6-OHDA during lactation period and infancy using the mouse model. The Si-based agent safeguards against the degradation and neuronal cell death of dopaminergic neurons and loss of dopaminergic fibers in the striatum (STR) and ventral tegmental area (VTA) caused by 6-OHDA. Furthermore, the Si-based agent exhibits a neuroprotective effect on the length of axon initial segment (AIS) in the layer 2/3 (L2/3) neurons of the medial prefrontal cortex (mPFC). As a result, the Si-based agent mitigates hyperactive behavior in a juvenile neurotoxic mouse model induced by 6-OHDA. These results suggest that the Si-based agent serves as an effective neuroprotectant and antioxidant against neurotoxic effects in the brain, offering the possibility of the Si-based agent as a neuroprotectant for nervous system diseases.
Keywords: 6-hydroxydopamine; Dopaminergic neuron; Hyperactivity; Neuroprotection; Neurotoxin; Si-based agent.
Copyright © 2024 The Authors. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no conflict of interest.
Similar articles
-
Susceptibility of ascending dopamine projections to 6-hydroxydopamine in rats: effect of hypothermia.Neuroscience. 2002;115(4):1281-94. doi: 10.1016/s0306-4522(02)00385-8. Neuroscience. 2002. PMID: 12453497
-
Neuroprotective effect of trans-cinnamaldehyde on the 6-hydroxydopamine-induced dopaminergic injury.Biol Pharm Bull. 2013;36(12):1928-35. doi: 10.1248/bpb.b13-00537. Biol Pharm Bull. 2013. PMID: 24292051
-
Ukgansan protects dopaminergic neurons from 6-hydroxydopamine neurotoxicity via activation of the nuclear factor (erythroid-derived 2)-like 2 factor signaling pathway.Neurochem Int. 2019 Jan;122:208-215. doi: 10.1016/j.neuint.2018.11.021. Epub 2018 Nov 30. Neurochem Int. 2019. PMID: 30508559
-
Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.BMC Neurosci. 2019 Dec 20;20(1):61. doi: 10.1186/s12868-019-0543-3. BMC Neurosci. 2019. PMID: 31862005 Free PMC article.
-
Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats.J Toxicol Sci. 2013 Feb;38(1):25-33. doi: 10.2131/jts.38.25. J Toxicol Sci. 2013. PMID: 23358137
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials